Brief: Biodexa Announces Activation Of First Clinical Study Site For Phase 3 Trial In Familial Adenomatous Polyposis
25/06/2025 13:38
June 25 (Reuters) - Biodexa Pharmaceuticals PLC 5MP1y.F: BIODEXA ANNOUNCES ACTIVATION OF FIRST CLINICAL STUDY SITE FOR PHASE 3 SERENTA TRIAL IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP) Source text: ID:nGNX8gF5Cm Further company coverage: [5MP1y.F] ((Reuters.Briefs@thomsonreuters.com;))